Major shareholders can include individual investors, mutual funds, hedge funds, or institutions.
The company was founded in May 2015 and is headquartered in Somerset, NJ. Company profile page for Legend Biotech Corp including stock price, company news, press releases, executives, board members, and contact information Legend operates in the USA, mainland China and Ireland.By continuing to use our site, you agree to terms on our
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Shift4, Dada, Legend Raise Over $1 Billion in U.S. IPO SurgeLegend Biotech to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare ConferenceLegend Biotech Reports Second Quarter 2020 Financial ResultsBeiGene Appoints Corsee Sanders, Ph.D. to its Board of DirectorsCommodities Are the Place to Be, Former Cantor CEO Says2101 Cottontail Lane Minimum 15 minutes delayed.By continuing to use our site, you agree to terms on our Legend Biotech Corp. is a holding company which engages in the discovery and development of novel cell therapies for oncology and other indications.
Aug 2, 2020 at 6:00 PM EDT Legend Biotech Corp is a clinical-stage biopharmaceutical company.
Their forecasts range from $37.00 to $55.00. Touch device users, explore by touch or with swipe gestures. On average, they anticipate Legend Biotech's share price to reach $50.67 in the next year.
{"OrganizationDocuments":[{"Documents":[{"document":[{"reportDateGroup":[{"reportDate":"2011-06-09","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-05-17","tradeTypeGroup":[{"numTransactions":"3","tradeType":"D"},{"numTransactions":"1","tradeType":"A"}]},{"reportDate":"2011-05-16","tradeTypeGroup":[{"numTransactions":"2","tradeType":"D"},{"numTransactions":"8","tradeType":"A"}]},{"reportDate":"2011-05-13","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-12","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-11","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-02","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-03-10","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-02-17","tradeTypeGroup":[{"numTransactions":"4","tradeType":"D"},{"numTransactions":"2","tradeType":"A"}]},{"reportDate":"2011-02-15","tradeTypeGroup":[{"numTransactions":"8","tradeType":"A"},{"numTransactions":"1","tradeType":"D"}]}]}]}]}]}Legend Biotech started at overweight with $50 stock price target at J.P. Morgan Find the latest Legend Biotech Corporation (LEGN) stock quote, history, news and other vital information to help you with your stock trading and investing. Legend operates in the USA, mainland China and Ireland.
Legend Biotech is a multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies with the ultimate goal of … It carries out its operations through the North America, and China geographical segments.
Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Legend Biotech against related stocks people have also bought.
Institutional Ownership and Shareholders Legend Biotech Corp (KY:52490G102) has 126 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
Stock analysis for Legend Biotech Corp (LEGN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Data Provided by Refinitiv.
This suggests a possible upside of 3.6% from the stock's current price.
Minimum 15 minutes delayed. Their forecasts range from $37.00 to $55.00. United StatesSorry, no quarterly data is available at this time.Sorry, no quarterly data is available at this time.Shift4, Dada, Legend Raise Over $1 Billion in U.S. IPO SurgeLegend Biotech to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare ConferenceLegend Biotech Reports Second Quarter 2020 Financial ResultsBeiGene Appoints Corsee Sanders, Ph.D. to its Board of DirectorsWhen autocomplete results are available use up and down arrows to review and enter to select. Copyright © 2020 MarketWatch, Inc. All rights reserved. Legend Biotech Corp (KY:52490G102) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size.
The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue …
5 equities research analysts have issued 12 month price objectives for Legend Biotech's stock.